Cambridge Cognition are attending the Collaborating for Novel Solutions (CNS) Summit: 16th-19th November 2017.
Evolocumab Phase 3 Cognitive Function Study Results Published in the New England Journal of Medicine
Cambridge Cognition and Amgen announce that the New England Journal of Medicine (NEJM) published results from the evolocumab cognitive function trial, which was conducted in a subset of patients enrolled in the randomized, placebo-controlled evolocumab cardiovascular outcomes study.
PhD student Claire Burley was one of four winners of our CANTAB Research Grant for 2016. Claire was awarded our UK award for her study titled 'Multi-modal assessment of brain health across the lifespan and between fitness groups. Magnetic resonance imaging (MRI) meets Doppler ultrasound, cognitive function and measures of well-being'. Having now completed the majority of her research, Claire tells us more about her research project and how The CANTAB Research Grant has helped.
Cognition is essential for everyday functioning - here's why.